Literature DB >> 32755403

Mid to Late Life Hypertension Trends and Cerebral Small Vessel Disease in the Framingham Heart Study.

Rodica Elena Petrea1,2, Adrienne O'Donnell2,3, Alexa S Beiser1,2,3, Mohammad Habes4, Hugo Aparicio1,2, Charles DeCarli5, Sudha Seshadri1,2,4, Jose Rafael Romero1,2.   

Abstract

The duration and lifetime pattern of hypertension is related to risk of stroke and dementia. In turn, cerebral small vessel disease (CSVD) is the most frequent form of cerebrovascular disease underlying dementia and stroke. Thus, study of the relation of mid to late life hypertension trends with CSVD late in life will help understand hypertension's role and inform preventive efforts of CSVD consequences. We studied 1686 Framingham Heart Study Offspring cohort participants free of stroke and dementia, who were examined in mid and late life, and had available brain magnetic resonance imaging during late life. We related hypertension trends between mid and late life (normotension-normotension N-N, normotension-hypertension N-H, hypertension-hypertension H-H) to cerebral microbleeds and covert brain infarcts (CBI), overall and stratified by brain topography. We used multivariable logistic regression analyses to calculate odds ratio and 95% CIs for CSVD measures. The prevalence of CSVD in late life was 8% for cerebral microbleeds and 13% for covert brain infarcts and increased with longer hypertension exposure across all brain regions. Compared with the trend pattern of N-N, both N-H and H-H trends had higher odds of mixed cerebral microbleeds (2.71 [1.08-6.80], and 3.44 [1.39-8.60], respectively); H-H also had higher odds of any cerebral microbleeds or covert brain infarcts (1.54 [1.12-2.20]), and any covert brain infarcts (1.55 [1.08-2.20]). The burden of CSVD also increased with longer hypertension exposure. Our results highlight hypertension having a major role in subclinical CSVD, across subtypes and brain regions, and call attention to improve recognition and treatment of hypertension early in life.

Entities:  

Keywords:  cerebral small vessel diseases; epidemiology; hypertension; magnetic resonance imaging; odds ratio

Mesh:

Year:  2020        PMID: 32755403      PMCID: PMC7577565          DOI: 10.1161/HYPERTENSIONAHA.120.15073

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

Review 1.  Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.

Authors:  Hans-Christian Koennecke
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study.

Authors:  Toshio Imaizumi; Yoshifumi Horita; Yuji Hashimoto; Jun Niwa
Journal:  J Neurosurg       Date:  2004-12       Impact factor: 5.115

Review 4.  Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Salim S Virani; Clifton W Callaway; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Stephanie E Chiuve; Mary Cushman; Francesca N Delling; Rajat Deo; Sarah D de Ferranti; Jane F Ferguson; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Pamela L Lutsey; Jason S Mackey; David B Matchar; Kunihiro Matsushita; Michael E Mussolino; Khurram Nasir; Martin O'Flaherty; Latha P Palaniappan; Ambarish Pandey; Dilip K Pandey; Mathew J Reeves; Matthew D Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Uchechukwu K A Sampson; Gary M Satou; Svati H Shah; Nicole L Spartano; David L Tirschwell; Connie W Tsao; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2018-01-31       Impact factor: 29.690

Review 5.  Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.

Authors:  Steven M Greenberg; Andreas Charidimou
Journal:  Stroke       Date:  2018-01-15       Impact factor: 7.914

6.  Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia.

Authors:  Keenan A Walker; A Richey Sharrett; Aozhou Wu; Andrea L C Schneider; Marilyn Albert; Pamela L Lutsey; Karen Bandeen-Roche; Josef Coresh; Alden L Gross; B Gwen Windham; David S Knopman; Melinda C Power; Andreea M Rawlings; Thomas H Mosley; Rebecca F Gottesman
Journal:  JAMA       Date:  2019-08-13       Impact factor: 56.272

7.  Cerebral Microbleeds Are Associated With an Increased Risk of Stroke: The Rotterdam Study.

Authors:  Saloua Akoudad; Marileen L P Portegies; Peter J Koudstaal; Albert Hofman; Aad van der Lugt; M Arfan Ikram; Meike W Vernooij
Journal:  Circulation       Date:  2015-07-02       Impact factor: 29.690

8.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.

Authors:  O R Benavente; C S Coffey; R Conwit; R G Hart; L A McClure; L A Pearce; P E Pergola; J M Szychowski
Journal:  Lancet       Date:  2013-05-29       Impact factor: 79.321

9.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.

Authors:  Jon B Toledo; Steven E Arnold; Kevin Raible; Johannes Brettschneider; Sharon X Xie; Murray Grossman; Sarah E Monsell; Walter A Kukull; John Q Trojanowski
Journal:  Brain       Date:  2013-07-10       Impact factor: 13.501

10.  Blood pressure from mid- to late life and risk of incident dementia.

Authors:  Emer R McGrath; Alexa S Beiser; Charles DeCarli; Kendra L Plourde; Ramachandran S Vasan; Steven M Greenberg; Sudha Seshadri
Journal:  Neurology       Date:  2017-11-08       Impact factor: 9.910

View more
  6 in total

1.  Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice.

Authors:  Mafalda Cacciottolo; Todd E Morgan; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2021-02-28       Impact factor: 5.133

2.  Trimethylamine N-oxide promotes demyelination in spontaneous hypertension rats through enhancing pyroptosis of oligodendrocytes.

Authors:  Xiaotan Ji; Long Tian; Shenna Niu; Shumei Yao; Chuanqiang Qu
Journal:  Front Aging Neurosci       Date:  2022-08-22       Impact factor: 5.702

3.  Does the Internal Carotid Artery Attenuate Blood-Flow Pulsatility in Small Vessel Disease? A 7 T 4D-Flow MRI Study.

Authors:  Rick J van Tuijl; Ynte M Ruigrok; Lennart J Geurts; Irene C van der Schaaf; Geert Jan Biessels; Gabriël J E Rinkel; Birgitta K Velthuis; Jaco J M Zwanenburg
Journal:  J Magn Reson Imaging       Date:  2022-01-07       Impact factor: 5.119

Review 4.  Hypertension-induced cognitive impairment: from pathophysiology to public health.

Authors:  Zoltan Ungvari; Peter Toth; Stefano Tarantini; Calin I Prodan; Farzaneh Sorond; Bela Merkely; Anna Csiszar
Journal:  Nat Rev Nephrol       Date:  2021-06-14       Impact factor: 42.439

5.  Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank.

Authors:  Danielle Newby; Laura Winchester; William Sproviero; Marco Fernandes; Dai Wang; Andrey Kormilitzin; Lenore J Launer; Alejo J Nevado-Holgado
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 6.  Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease.

Authors:  Rajesh N Kalaria; Diego Sepulveda-Falla
Journal:  Am J Pathol       Date:  2021-07-28       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.